This Biomarker Predicts Very Long-Term JIA Outcomes

(MedPage Today) -- Patients with juvenile idiopathic arthritis (JIA) who carried the HLA-B27 genetic marker tended to have worse long-term outcomes, including lower rates of drug-free remission, in a prospective Scandinavian study.
Among 434 patients...